October 2024

RHEUMATOLOGY

INSIGHTS FROM ERIC M. RUDERMAN, MD, AT EULAR 2024

​Eric M. Ruderman, MD, represented the Division of Rheumatology at Northwestern Medicine while attending the European Congress of Rheumatology EULAR 2024 meeting in Vienna, Austria. While at the meeting, Dr. Ruderman shared key takeaways with RheumNow. 

Psoriatic Arthritis Topic Panel: EULAR 2024

Dr. Ruderman joined a diverse panel of psoriatic arthritis experts, discussing their favorite presentations from the EULAR meeting. 

Do MRI Changes at the Spine and SI Joints in Treatment of AxSpA Matter?

Dr. Ruderman discusses the impact of biologic therapies on structural changes in axial spondyloarthritis. He mentions two abstracts presented at a meeting that looked at the effects of these therapies on the joints. 

A Puzzling Era in Global Drug Development

Dr. Ruderman shares an interesting trend at EULAR 2024, noting several large phase 3 trials of new molecules being developed in China, many of which are being developed only for use in China.

Do We Need More IL-17 and JAK Inhibitors in Spondyloarthritis?

​Dr. Ruderman walks through various abstracts presented at EULAR 2024, offering his unique perspective. 
​Eric M. Ruderman, MD, Professor of Rheumatology at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like